Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 191

Digital Turbine recruits Mobile Posse

SoftBank is set to exit the mobile content discovery platform in an acquisition by Digital Turbine that is reportedly priced at $66m.

Feb 19, 2020

Cashlez eyes IPO cash injection

The payment app developer, which counts Sumitomo among its investors, is seeking $7.3m in a flotation on the Indonesia Stock Exchange.

Feb 17, 2020

Revolution hits public markets in $238m IPO

The precision cancer therapy developer, based on research from several universities, floated at the top of an upsized range and saw its price continue to rise post-IPO.

Feb 14, 2020

Revolution hits public markets in $238m IPO

The precision cancer therapy developer, which counts Sanofi as a significant shareholder, floated at the top of an upsized range and saw its price continue to rise post-IPO.

Feb 14, 2020

Flywire balances $120m with Simplee acquisition

Goldman Sachs led a round that valued Flywire at more than $1bn as the digital payment processor acquired American Express-backed Simplee.

Feb 14, 2020

EDF plugs into Pod Point in $130m deal

Legal & General increased its stake in the charging infrastructure operator to 23% while EDF purchased a majority share in a $130m deal.

Feb 14, 2020

Hollar attracts Five Below for acquisition

Comcast Ventures has exited Hollar in an acquisition by Five Below, which is reportedly set to shut down the budget e-commerce platform.

Feb 14, 2020

Essential reaches its end

Less than three years after raising money at a valuation of up to $1bn, Essential is shutting down after low sales of its alternative Android smartphone.

Feb 13, 2020

P4 Diagnostix picks up Strand Diagnostics assets

Biopsy verification technology developer Strand Diagnostics had raised $7.5m of a commitment from Nantworks originally slated to reach $30m.

Feb 13, 2020

Beam Therapeutics brings IPO to $207m close

The genomic drug developer, spun out of Harvard University, has completed its initial public offering, boosting its size from $180m to $207m.

Feb 12, 2020
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here